Baxter International Inc.’s biopharmaceuticals business plans to create a research-and-development center near Boston. The biopharmaceuticals business, which Deerfield-based Baxter plans to spin off next summer as Baxalta Inc., expects to have 400 research-and-development employees at the center as well as others involved in areas such as business development and oncology.
Read more at Newsfeed.